| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome
|
Lussana, Federico
|
|
2016
|
22 |
11 |
p. 1983-1987
5 p.
|
artikel
|
| 2 |
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features
|
Rasche, Leo
|
|
2016
|
22 |
11 |
p. 1988-1996
9 p.
|
artikel
|
| 3 |
Allogeneic Hematopoietic Stem Cell Transplantation in Thirty-Four Pediatric Cases of Mucopolysaccharidosis—A Ten-Year Report from the China Children Transplant Group
|
Wang, Jianmin
|
|
2016
|
22 |
11 |
p. 2104-2108
5 p.
|
artikel
|
| 4 |
An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host Disease
|
Treister, Nathaniel
|
|
2016
|
22 |
11 |
p. 2084-2091
8 p.
|
artikel
|
| 5 |
A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease
|
Khandelwal, Pooja
|
|
2016
|
22 |
11 |
p. 2011-2018
8 p.
|
artikel
|
| 6 |
Augmenting Autologous Stem Cell Transplantation to Improve Outcomes in Myeloma
|
Maybury, Bernard
|
|
2016
|
22 |
11 |
p. 1926-1937
12 p.
|
artikel
|
| 7 |
Clinical Application of the Dried Blood Spot Method in the Measurement of Blood Busulfan Concentration
|
Matsumoto, Kana
|
|
2016
|
22 |
11 |
p. 1968-1973
6 p.
|
artikel
|
| 8 |
Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation
|
Luskin, Marlise R.
|
|
2016
|
22 |
11 |
p. 1961-1967
7 p.
|
artikel
|
| 9 |
Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies
|
Baker, Melissa
|
|
2016
|
22 |
11 |
p. 2047-2055
9 p.
|
artikel
|
| 10 |
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia
|
Choi, Inpyo
|
|
2016
|
22 |
11 |
p. 2065-2076
12 p.
|
artikel
|
| 11 |
Donor Lymphocyte Infusion–Mediated Graft-versus-Host Responses in a Preclinical Swine Model of Haploidentical Hematopoietic Cell Transplantation
|
Duran-Struuck, Raimon
|
|
2016
|
22 |
11 |
p. 1953-1960
8 p.
|
artikel
|
| 12 |
Editorial Board
|
|
|
2016
|
22 |
11 |
p. A6-
1 p.
|
artikel
|
| 13 |
HapLogic: A Predictive Human Leukocyte Antigen–Matching Algorithm to Enhance Rapid Identification of the Optimal Unrelated Hematopoietic Stem Cell Sources for Transplantation
|
Dehn, Jason
|
|
2016
|
22 |
11 |
p. 2038-2046
9 p.
|
artikel
|
| 14 |
Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes
|
Kanda, Junya
|
|
2016
|
22 |
11 |
p. 2031-2037
7 p.
|
artikel
|
| 15 |
Hematopoietic Cell Transplantation for Richter Syndrome
|
El-Asmar, Jessica
|
|
2016
|
22 |
11 |
p. 1938-1944
7 p.
|
artikel
|
| 16 |
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy
|
Rojek, Katarzyna
|
|
2016
|
22 |
11 |
p. 2100-2103
4 p.
|
artikel
|
| 17 |
Impact of Graft–Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Nonmalignant Disease
|
Kudek, Matthew R.
|
|
2016
|
22 |
11 |
p. 2019-2024
6 p.
|
artikel
|
| 18 |
Masthead (Purpose and Scope)
|
|
|
2016
|
22 |
11 |
p. A4-
1 p.
|
artikel
|
| 19 |
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
|
Mulé, Matthew P.
|
|
2016
|
22 |
11 |
p. 1974-1982
9 p.
|
artikel
|
| 20 |
Officers and Directors of ASBMT
|
|
|
2016
|
22 |
11 |
p. A10-
1 p.
|
artikel
|
| 21 |
Outcomes after Unrelated Umbilical Cord Blood Transplantation for Children with Osteopetrosis
|
Chiesa, Robert
|
|
2016
|
22 |
11 |
p. 1997-2002
6 p.
|
artikel
|
| 22 |
Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee
|
Palmer, Jeanne
|
|
2016
|
22 |
11 |
p. 1915-1925
11 p.
|
artikel
|
| 23 |
Practice Patterns and Preferences Among Hematopoietic Cell Transplantation Clinicians
|
Wood, William A.
|
|
2016
|
22 |
11 |
p. 2092-2099
8 p.
|
artikel
|
| 24 |
Quantitation of Human Cells that Produce Neutrophils and Platelets in Vivo Obtained from Normal Donors Treated with Granulocyte Colony–Stimulating Factor and/or Plerixafor
|
Miller, Paul H.
|
|
2016
|
22 |
11 |
p. 1945-1952
8 p.
|
artikel
|
| 25 |
Reply to: Using Appropriate Methods in Cost-Effectiveness Analyses: The Case of Allogeneic Hematopoietic Cell Transplantation in Sickle Cell Disease
|
Arnold, Staci D.
|
|
2016
|
22 |
11 |
p. 2110-2111
2 p.
|
artikel
|
| 26 |
Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen–Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency
|
Li Pira, Giuseppina
|
|
2016
|
22 |
11 |
p. 2056-2064
9 p.
|
artikel
|
| 27 |
Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor–Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation
|
Bejanyan, Nelli
|
|
2016
|
22 |
11 |
p. 2025-2030
6 p.
|
artikel
|
| 28 |
Table of Contents
|
|
|
2016
|
22 |
11 |
p. A16-A28
nvt p.
|
artikel
|
| 29 |
The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucémie de l'Enfant et de L'Adolescent Study
|
Visentin, Sandrine
|
|
2016
|
22 |
11 |
p. 2003-2010
8 p.
|
artikel
|
| 30 |
The Persistence of Minimal Residual Disease in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: We Know It's Bad, Now What?
|
Leonard, Jessica T.
|
|
2016
|
22 |
11 |
p. 1913-1914
2 p.
|
artikel
|
| 31 |
Trajectories of Quality of Life after Hematopoietic Cell Transplantation: Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network 0902 Data
|
Jim, Heather S.L.
|
|
2016
|
22 |
11 |
p. 2077-2083
7 p.
|
artikel
|
| 32 |
Using Appropriate Methods in Cost-Effectiveness Analyses: The Case of Allogeneic Hematopoietic Cell Transplantation in Sickle Cell Disease
|
Thielen, Frederick W.
|
|
2016
|
22 |
11 |
p. 2109-2110
2 p.
|
artikel
|
| 33 |
Using Molecular Data in Allogeneic Hematopoietic Cell Transplantation Outcomes for Acute Myeloid Leukemia: Underestimating True Tumor Diversity?
|
Hamilton, Betty Ky
|
|
2016
|
22 |
11 |
p. 1911-1912
2 p.
|
artikel
|
Tijdschrift beschrijving